- Provider Resource
- Home
- Browse Provider Resource
- Refer a patient
The Northwest Heart Failure Collaborative (NWHFC): Project ECHO is a bimonthly case conference series that aims to improve the care of patients with heart failure by increasing access to continuing education and interdisciplinary case consultations. This unique training program builds on an existing education-practice partnership between UW Medicine and the UW School of Nursing. Grant funding is provided by the Health Services and Research Administration (HRSA).
Format:
1-hour, online, case conference, 1st & 3rd Wednesdays @ Noon PDT
Content:
The first 15 minutes will include a heart failure education presentation followed by 45 minutes of audience-submitted case presentations with interactive, interdisciplinary discussion
Cost:
FREE to participate
Target Audience:
Community Providers (MD/DO, ARNP/PA, RN, PharmD, Social Work and Allied Health)
Please REGISTER to receive webinar log-in information and CE/CME credit. Download the NWHFC Participant Packet for instructions and resources on attending the webinars.
Videos
Hospital Readmission Reduction Program: Evidence Against Efficacy
Todd Dardas, MD, discusses several treatments for reducing readmission, such as evidence-based medications and disease management programs.
Public Reporting in Heart Failure
Todd Dardas, MD, discusses public reporting on heart failure and the quality of care by patient choice based on accurate, reliable, available information.
Heart Failure Care Guidelines to Improve Management in Primary Care
Alisha Peterson, BSN, RN, CCRN, gives a lecture on the need to improve heart failure management at the community level.
Cardiovascular Outcomes with Novel Hypoglycemics
Kevin O'Brien, MD discusses the epidemiologic association of Type 2 diabetes with Heart Failure.
Remote Pulmonary Pressure Monitoring
Todd Dardas, MD, MS, describes the function of the CardioMems system and discusses the results of the CHAMPION trials.
Transitions of Care: Discharge & Medication Reconciliation Process
Beatrice Wong, PharmD, BCPS, discusses three factors that can be identified in patients with heart failure that would increase the likelihood of hospital readmission.
Janice A. Sabin, PhD, MSW, defines implicit bias and how to recognize how implicit bias may be operating in a clinical setting.
Heart Failure Transition of Care Programs
Hilary Law, MN, RN, CHFN, Heart Failure Transition Nurse at the University of Washington Medical Center, stresses the importance of transition of care programs.
The Role of the Kidney in Heart Failure
Todd Dardas, MD, MS, discusses the different mechanisms of renal dysfunction in heart failure and different approaches to addressing renal dysfunction.
George Demiris PhD, FACMI, provides an overview of the current status and potential of tele-health in supporting home based symptom management.
Putting It Together: PHARMACOLOGY
Kevin D. O’Brien, MD, FAHA, addresses issues of polypharmacy and costs for patients.
Hidden Issues & Challenges in Managing Heart Failure Patients: Psychosocial Aspect of Care
Alice Chang, LICSW, CCTSW identifies psychosocial factors related to care planning and management of heart failure patients.
Depression in Heart Failure: Part 1
Jean Tang, PhD, PMHNP-BC, APRN, describes shared symptoms between depression and heart failure. Dr. Tang also discusses ways to recognize risk factors for comorbid depression and heart failure.
Aldosterone Receptor Inhibitors: Effective and Forgotten
Todd Dardas, MD, MS talks about the effectiveness of Aldosterone Receptor Inhibitors and how to identify potential complications and adverse effects of Aldosterone Receptor Blockade.
Clinical Applications of Beta Blocker Therapy
Claudius Mahr, FACC, FESC, outlines clinical applications of beta blocker therapy and discusses drug selection and heart failure risk stratification.
Angiotensin-Converting Enzyme Inhibitors
Todd Dardas, MD, MS, explains how to identify Angiotensin-converting enzyme inhibitors for use in Stage B-D heart failure.
Kevin Douglas O'Brein, MD, FAHA, describes why patients with heart failure can have large differences in central venous pressure (CVP) and pulmonary capillary wedge pressure (PCWP).
Staging and Prognosis of Heart Failure
Jennifer Beckman, MSN, ARNP, CHFN, describes the stages of heart failure and how to identify advanced heart failure patients and when to refer for advanced treatment options.
Heart Failure: Identifying the Syndrome and Burden of Disease
Todd Dardas, MD, MS, defines factors that contribute to the prevalence of heart failure, identifies modifiable risk factors that are most responsible for reducing prevalence of heart failure.
Left Ventricular Assist Devices: When to Consider and What to Expect?
Claudius Mahr, FACC, FESC, Associate Professor of Clinical Medicine and Cardiac Surgery at UW Regional Heart Center leads a panel discussion on when to consider the use of an LVAD and what to expect.
Internal Cardioverter Defibrillators: Issues of Over and Under Utilization
Todd Dardas, MD, MS, an attending physician in heart failure transplant cardiology at the University of Washington Medical Center, discusses the role of symptoms in ICD implant determination.
Detecting and Evaluating Cognitive Impairment in Heart Failure Patients
Tatiana Sadak, PhD, PMHNP, ARNP, Associate Professor of Geriatric Mental Health at the Nursing University of Washington School of Nursing, describes the prevalence and patterns of cognitive impairment in heart failure patients.
Preventing Heart Failure Admissions: Invasive Hemodynamic Monitoring
Gregory Wood, MD, MS, reviews the indications for CardioMEMS implantation, the basic principles for medication adjustment when managing a patient by PA pressure and describes the phases of management of a CardioMEMS patient.
Patient Reported Outcome Measures Implications for Engaging Patients
Danielle Lavallee, PharmD, PhD discusses patient-reported outcomes (PROs) and itdentifies callenges and future opportunities for PRO implementation in clinical settings.
Approach to Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction
Jordan Prutkin, MD, MHS, covers assessing the impact of AF on heart failure with reduced ejection fraction, the application of anticoagulation management and identifying when to use rate and rhythm management options.
Adherence and Medications to Avoid in Heart Failure
Jennifer Beckman, MSN, ARNP, CHFN, discusses general principles related to medication avoidance and adherence specific to the heart failure population.
ISHLT 2017 Annual Meeting: Updates on VADs
Shin Lin, MD, PhD gives an overview on the two basic types of left ventricular assist devices (LVAD).
Cardiac Resynchronization Therapy: How Does It Work and For Whom?
Nazem Akoum, MD, gives a lecture on how the electrical mechanical association works in within the heart.
Intersections of Palliative Care and Advanced Heart Failure
James Fausto, MD, FAAHPM explains palliative care in end stage heart failure and reviews treatment options of Dyspnea.
Diastolic Heart Failure: Review and State-of-the-Art
Todd Dardas, MD, MS discusses Diastolic Heart Failure.